1. Home
  2. HRMY vs AIR Comparison

HRMY vs AIR Comparison

Compare HRMY & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • AIR
  • Stock Information
  • Founded
  • HRMY 2017
  • AIR 1951
  • Country
  • HRMY United States
  • AIR United States
  • Employees
  • HRMY N/A
  • AIR N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • AIR Aerospace
  • Sector
  • HRMY Health Care
  • AIR Industrials
  • Exchange
  • HRMY Nasdaq
  • AIR Nasdaq
  • Market Cap
  • HRMY 2.2B
  • AIR 2.3B
  • IPO Year
  • HRMY 2020
  • AIR 1988
  • Fundamental
  • Price
  • HRMY $34.56
  • AIR $61.81
  • Analyst Decision
  • HRMY Strong Buy
  • AIR Strong Buy
  • Analyst Count
  • HRMY 8
  • AIR 4
  • Target Price
  • HRMY $54.38
  • AIR $81.50
  • AVG Volume (30 Days)
  • HRMY 557.4K
  • AIR 166.6K
  • Earning Date
  • HRMY 02-25-2025
  • AIR 03-20-2025
  • Dividend Yield
  • HRMY N/A
  • AIR N/A
  • EPS Growth
  • HRMY N/A
  • AIR N/A
  • EPS
  • HRMY 2.11
  • AIR 0.28
  • Revenue
  • HRMY $681,879,000.00
  • AIR $2,571,600,000.00
  • Revenue This Year
  • HRMY $25.11
  • AIR $19.84
  • Revenue Next Year
  • HRMY $19.19
  • AIR $6.37
  • P/E Ratio
  • HRMY $16.46
  • AIR $223.84
  • Revenue Growth
  • HRMY 25.83
  • AIR 18.53
  • 52 Week Low
  • HRMY $28.14
  • AIR $54.71
  • 52 Week High
  • HRMY $41.61
  • AIR $76.34
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 35.54
  • AIR 30.31
  • Support Level
  • HRMY $37.03
  • AIR $64.36
  • Resistance Level
  • HRMY $39.91
  • AIR $65.42
  • Average True Range (ATR)
  • HRMY 1.34
  • AIR 1.63
  • MACD
  • HRMY -0.58
  • AIR -0.75
  • Stochastic Oscillator
  • HRMY 9.86
  • AIR 0.88

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in two segments namely Aviation Services and Expeditionary Services. The Aviation Services segment consists of aftermarket support and services businesses that provide spares and maintenance support for aircraft operated by it's commercial and government/defense customers. The Expeditionary Services segment consists of businesses that provide products and services supporting the movement of equipment and personnel by the U.S. Department of Defense, foreign governments, and non-governmental organizations. It generates a majority of its revenue from the Aviation Services Segment.

Share on Social Networks: